Gloucestershire Royal Hospital Gloucester CMV Saliva PCR

The procurement process was undertaken by the Gloucestershire Hospitals NHS Foundation Trust, focusing on pathology services with the title "Gloucestershire Royal Hospital Gloucester CMV Saliva PCR". This tender, classified under the CPV code 85111800 for pathology services, pertains to the supply of CMV Saliva PCR testing services. The contract process has reached the Award stage, and although initially a lot was cancelled, an award was made to The Royal Devon University Healthcare NHS Foundation Trust.

The procurement method was a limited procedure, conducted without prior publication, positioning itself as a Direct Award due to the procurement requirements falling outside usual directive scopes. Notably, the contract was signed on 14 April 2025, at a value of £1,750, and will be executed at the Gloucester Royal Hospital, located in region UKK13. This procurement presents significant opportunities for businesses specialising in healthcare services, particularly those offering innovative and reliable pathology services.

Companies that have the infrastructure and capability to offer specialised medical testing and diagnostics, especially in the CMV Saliva PCR domain, could see growth by engaging in similar contracts. Large healthcare providers, like the awarded supplier, The Royal Devon University Healthcare NHS Foundation Trust, are well-positioned to compete, given their established scale and resources to meet the demands and expectations of such specialised services within the NHS framework.